(1)
A SYSTEMATIC REVIEW ON A COMPREHENSIVE EVALUATION OF CLINICAL PROGNOSTIC VARIABLES AND NEW BIOMARKERS FOR HEAD AND NECK CANCER OUTCOME. Journal of Pharmaceutical Negative Results 2022, 3026-3049. https://doi.org/10.47750/pnr.2022.13.S08.380.